Pfizer's COVID antiviral Paxlovid gains full US approval May 26, 2023 Washington [US],May 26: The U.S. Food and Drug Administration granted full approval to Pfizer's (PFE.N) oral antiviral COVID-19 treatment Paxlovid. Read More ..